| |
| |
|
| Insider
Information: |
Colella Samuel D |
| Relationship: |
Director |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
203,276 |
|
|
Indirect Shares
|
2,453,199 |
|
|
| Direct
Value |
$752,210 |
|
|
|
Indirect Value
|
$21,088,892 |
|
|
| Total
Shares |
2,656,475 |
|
|
| Total
Value |
$21,841,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 130.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
Director |
2014-10-01 |
5,305 |
2014-10-01 |
54,348 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
36,862 |
2010-01-26 |
2,183,128 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
|
Insulet Corp |
PODD |
Former 10% Owner |
2007-05-14 |
0 |
2007-05-14 |
89,372 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2007-06-06 |
0 |
2008-07-21 |
13,247 |
Premium* |
|
|
Fluidigm Corp |
FLDM |
Director |
2020-03-11 |
161,109 |
2020-03-11 |
78,159 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director, 10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2016-06-08 |
4 |
B |
$14.00 |
$9,999,990 |
I/I |
714,285 |
20,739 |
2.25 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2016-06-20 |
4 |
B |
$13.70 |
$93,833 |
D/D |
6,778 |
6,778 |
3.92 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2016-06-21 |
4 |
B |
$13.62 |
$255,766 |
D/D |
18,726 |
25,504 |
3.92 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2016-11-21 |
4 |
B |
$18.00 |
$599,994 |
I/I |
33,333 |
33,333 |
2.25 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2016-11-30 |
4 |
B |
$6.32 |
$126,470 |
D/D |
20,000 |
39,123 |
2.39 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2016-12-01 |
4 |
B |
$16.38 |
$163,807 |
I/I |
10,000 |
43,333 |
2.25 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2016-12-14 |
4 |
B |
$7.39 |
$36,935 |
D/D |
5,000 |
44,123 |
2.39 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2017-03-14 |
4 |
B |
$5.00 |
$49,973 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2017-05-09 |
4 |
B |
$5.93 |
$44,438 |
I/I |
7,500 |
17,500 |
2.1 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2017-06-05 |
4 |
B |
$17.01 |
$85,048 |
I/I |
5,000 |
5,000 |
2.25 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2017-08-08 |
4 |
B |
$2.77 |
$99,357 |
I/I |
35,895 |
53,395 |
2.1 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-08-06 |
4 |
B |
$7.02 |
$56,183 |
D/D |
8,000 |
115,481 |
2.39 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-08-07 |
4 |
B |
$6.86 |
$6,857 |
D/D |
1,000 |
116,481 |
2.39 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2019-08-08 |
4 |
B |
$10.74 |
$21,480 |
I/I |
2,000 |
45,333 |
2.17 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-08-08 |
4 |
B |
$6.65 |
$6,653 |
D/D |
1,000 |
117,481 |
2.39 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2019-08-27 |
4 |
B |
$5.19 |
$10,372 |
D/D |
2,000 |
119,481 |
2.39 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2020-03-10 |
4 |
B |
$2.77 |
$27,738 |
D/D |
10,000 |
151,109 |
2.39 |
% |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2020-03-11 |
4 |
B |
$2.65 |
$26,545 |
D/D |
10,000 |
161,109 |
2.39 |
% |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2010-12-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(550,000) |
61,301 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2011-02-15 |
4 |
D |
$13.50 |
$149 |
I/I |
(11) |
1,059,186 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2011-03-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(515,680) |
20,838 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-05-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(509,628) |
11,210 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(593,384) |
0 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-08-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(327,121) |
13,345 |
0 |
- |
|
| FLDM |
Fluidigm Corp |
Director |
– • – |
2013-11-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(700,627) |
0 |
0 |
- |
|
105 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
